These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. [Hageman factor deficiency (factor XII)--hemorrhage or thrombosis?]. Schott G; Lutze G Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):436-41. PubMed ID: 2414173 [TBL] [Abstract][Full Text] [Related]
31. Aortic valve replacement in a patient with factor XII deficiency: case report. Murakami T; Shibata T; Sasaki Y; Hosono M; Suehiro S; Kinoshita H J Heart Valve Dis; 2001 May; 10(3):377-9. PubMed ID: 11380103 [TBL] [Abstract][Full Text] [Related]
32. [Venous thromboembolism in connection with physical restraint]. Hem E; Opjordsmoen S; Sandset PM Tidsskr Nor Laegeforen; 1998 May; 118(14):2156-7. PubMed ID: 9656810 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic use of thrombolytic agents. Stambaugh RL; Alexander MR Am J Hosp Pharm; 1981 Jun; 38(6):817-24. PubMed ID: 7018230 [TBL] [Abstract][Full Text] [Related]
34. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism. Martinelli I; Cattaneo M; Panzeri D; Mannucci PM Thromb Haemost; 1997 Mar; 77(3):440-3. PubMed ID: 9065990 [TBL] [Abstract][Full Text] [Related]
35. Air travel and pulmonary embolism: "economy class syndrome". Bhatia V; Arora P; Parida AK; Singh G; Kaul U Indian Heart J; 2008; 60(6):608-11. PubMed ID: 19276509 [TBL] [Abstract][Full Text] [Related]
36. [Deep venous thromboses--established treatment procedures and new trends]. Seifried E Z Kardiol; 1993; 82 Suppl 2():49-59. PubMed ID: 8328209 [TBL] [Abstract][Full Text] [Related]
37. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro. Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599 [TBL] [Abstract][Full Text] [Related]
38. Controlled multicenter pilot study of urokinase- heparin and streptokinase in deep vein thrombosis. van de Loo JC; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Asbeck F; Marbet GA; Schmitt HE; Sewell AF; Duckert F Thromb Haemost; 1983 Oct; 50(3):660-3. PubMed ID: 6359570 [TBL] [Abstract][Full Text] [Related]
39. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction]. Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686 [TBL] [Abstract][Full Text] [Related]
40. [Recurrent venous thromboses in hypoplasia of the vena cava inferior and factor XII deficiency]. Halbmayer WM; Radek J; Duschet P; Lindeck G; Gschnait F; Czembirek H; Fischer M Dtsch Med Wochenschr; 1993 Oct; 118(43):1561-6. PubMed ID: 8223205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]